GENE ONLINE|News &
Opinion
Blog

2021-11-19| Special

New Research on Neoantigens and Tumor-targeting T-cells Marks Paradigm Shift in Countering Solid Tumors

by Isha Kapoor
Share To
Cancer immunotherapies based on therapeutic vaccination or transfer of tumor-infiltrating lymphocytes (TILs) are heralded as one of the most important advancements in the management of solid tumors. The precise identification of clinically relevant tumor antigens and their cognate TCRs is a critical foundation for such therapies.

However, the biggest challenge is the low frequency of these neoantigen-specific T-cells in peripheral blood lymphocytes (PBLs) and tumor-infiltrating lymphocytes. Thus, designing effective antigen screening methodology, in vitro TIL expansion, optimizing antigen validation has gained much attention recently.

In a breakthrough study, scientists from the Ludwig Institute of Cancer Research led by investigator Alexandre Harari and George Coukos, Director of the Lausanne Branch of the Ludwig Institute for Cancer Research, developed a highly efficient method, ‘NeoScreen,’ an in vitro TIL expansion and screening methodology that aims at sensitive identification of rare tumor (neo) antigens and of cognate T cell receptors (TCRs) expressed by tumor-infiltrating lymphocytes.

GO Prime with only $1.49 now

LATEST
Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19
2022-07-05
Breakthrough Zebrafish Genome Database Now Available
2022-07-05
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
Akebia Therapeutics Gains $55M Following Deal Termination by Otsuka Pharmaceutical
2022-07-04
EVENT
2022-07-27
BIO Asia–Taiwan 2022
Online and on-side
2022-08-03
BIOPLUS-INTERPHEX KOREA
Seoul
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top